# Impact of Digital Therapeutic on Metabolic Parameters

> **NCT04573296** · NA · COMPLETED · sponsor: **Vitadio s.r.o.** · enrollment: 100 (actual)

## Conditions studied

- Insulin Resistance
- Prediabetic State
- Diabetes Mellitus, Type 2
- Obesity

## Interventions

- **DEVICE:** Vitadio
- **BEHAVIORAL:** Conventional high-intensity lifestyle intervention program

## Key facts

- **NCT ID:** NCT04573296
- **Lead sponsor:** Vitadio s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-26
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04573296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04573296, "Impact of Digital Therapeutic on Metabolic Parameters". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04573296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*